PCSK9 and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome: In RCTs among patients with history of SAMS, there was high heterogeneity in the statin regimens and controls (placebo/non-daily dosing/ezetimibe/PCSK9 inhibitors).